• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠易激综合征患者的合并症及医疗服务利用情况

Comorbidity and use of health-care services among irritable bowel syndrome sufferers.

作者信息

Hillilä Markku T, Siivola Matti T, Färkkilä Martti A

机构信息

Helsinki University Central Hospital, Department of Medicine, Division of Gastroenterology, Hus, Finland.

出版信息

Scand J Gastroenterol. 2007 Jul;42(7):799-806. doi: 10.1080/00365520601113927.

DOI:10.1080/00365520601113927
PMID:17558902
Abstract

OBJECTIVE

Patients suffering from irritable bowel syndrome (IBS) have more somatic and psychiatric comorbidity and use more health-care services for comorbid conditions than do other patients. Little is known about the frequency of comorbid symptoms among IBS sufferers in the general population and their influence on use of health-care facilities. The objective of this study was to compare the frequency of somatic and psychiatric symptoms between IBS sufferers and controls in the general population, and to study how comorbidity rates are distributed among consulters and non-consulters and how they predict the use of health care-services.

MATERIAL AND METHODS

By means of a questionnaire sent to 5000 randomly selected adults IBS was identified according to the Rome II criteria. The questionnaire also covered upper GI symptoms, non-GI somatic symptoms, depression and anxiety. A logistic regression analysis with 26 variables was carried out to determine the independent predictors of health-care seeking for GI and non-GI complaints.

RESULTS

The response rate was 73% and prevalence of IBS 5.1% (95% CI 4.4-5.8%). Dyspeptic symptoms, somatic extra-GI symptoms and psychiatric symptoms were reported by 45%, 69% and 51% of IBS sufferers, respectively, and 6%, 35% and 27%, of controls, respectively. Visiting a physician because of GI complaints was associated with disturbing abdominal symptoms, but not with depression or anxiety. Of the present GI conditions, only dyspeptic symptoms were associated with an increased consultation rate also for non-GI complaints.

CONCLUSIONS

In the general population, both IBS consulters and non-consulters demonstrate high rates of comorbidity. Seeking health care for abdominal complaints is associated with abdominal symptoms rather than psychiatric comorbidity.

摘要

目的

肠易激综合征(IBS)患者比其他患者有更多的躯体和精神共病,并且因共病状况使用更多的医疗服务。对于普通人群中IBS患者共病症状的频率及其对医疗设施使用的影响知之甚少。本研究的目的是比较普通人群中IBS患者与对照组之间躯体和精神症状的频率,并研究共病率在就诊者和未就诊者中的分布情况以及它们如何预测医疗服务的使用。

材料与方法

通过向5000名随机选择的成年人发送问卷,根据罗马II标准确定IBS。问卷还涵盖上消化道症状、非胃肠道躯体症状、抑郁和焦虑。进行了一项包含26个变量的逻辑回归分析,以确定因胃肠道和非胃肠道疾病寻求医疗服务的独立预测因素。

结果

应答率为73%,IBS患病率为5.1%(95%可信区间4.4 - 5.8%)。分别有45%、69%和51% 的IBS患者报告有消化不良症状、非胃肠道躯体症状和精神症状,而对照组分别为6%、35%和27%。因胃肠道不适就诊与令人困扰的腹部症状相关,但与抑郁或焦虑无关。在目前的胃肠道疾病中,只有消化不良症状也与非胃肠道疾病的就诊率增加相关。

结论

在普通人群中,IBS就诊者和未就诊者均表现出较高的共病率。因腹部不适寻求医疗服务与腹部症状相关,而非精神共病。

相似文献

1
Comorbidity and use of health-care services among irritable bowel syndrome sufferers.肠易激综合征患者的合并症及医疗服务利用情况
Scand J Gastroenterol. 2007 Jul;42(7):799-806. doi: 10.1080/00365520601113927.
2
Prevalence, comorbidity and impact of irritable bowel syndrome in Norway.挪威肠易激综合征的患病率、合并症及影响
Scand J Gastroenterol. 2006 Jun;41(6):650-6. doi: 10.1080/00365520500442542.
3
Gastrointestinal complaints among subjects with depressive symptoms in the general population.普通人群中具有抑郁症状的受试者的胃肠道不适
Aliment Pharmacol Ther. 2008 Sep 1;28(5):648-54. doi: 10.1111/j.1365-2036.2008.03771.x. Epub 2008 Jun 28.
4
Why do subjects with irritable bowel syndrome seek health care for their symptoms?为什么肠易激综合征患者会因其症状寻求医疗护理?
Scand J Gastroenterol. 2007 Oct;42(10):1194-203. doi: 10.1080/00365520701320455.
5
Societal costs for irritable bowel syndrome--a population based study.肠易激综合征的社会成本——一项基于人群的研究。
Scand J Gastroenterol. 2010 May;45(5):582-91. doi: 10.3109/00365521003637211.
6
Comorbidity in irritable bowel syndrome.肠易激综合征中的共病情况。
Am J Gastroenterol. 2007 Dec;102(12):2767-76. doi: 10.1111/j.1572-0241.2007.01540.x. Epub 2007 Sep 26.
7
Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study.肠易激综合征与广泛性焦虑障碍密切相关:一项社区研究。
Aliment Pharmacol Ther. 2009 Sep 15;30(6):643-51. doi: 10.1111/j.1365-2036.2009.04074.x. Epub 2009 Jun 23.
8
Prevalence of irritable bowel syndrome: a community survey.肠易激综合征的患病率:一项社区调查。
Br J Gen Pract. 2004 Jul;54(504):495-502.
9
How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice.共病如何影响肠易激综合征患者的医疗保健费用?一般实践中的队列研究。
BMC Gastroenterol. 2010 Mar 17;10:31. doi: 10.1186/1471-230X-10-31.
10
Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications.全科医疗中肠易激综合征的共病现象:一个具有临床意义的显著特征。
Aliment Pharmacol Ther. 2004 Nov 15;20(10):1195-203. doi: 10.1111/j.1365-2036.2004.02250.x.

引用本文的文献

1
Efficacy of a single low dose of esketamine for patients with irritable bowel syndrome: study protocol for a randomised controlled trial.单次低剂量艾司氯胺酮治疗肠易激综合征患者的疗效:一项随机对照试验的研究方案
BMJ Open. 2025 Jun 23;15(6):e099793. doi: 10.1136/bmjopen-2025-099793.
2
Somatization symptomology and its association with stress in patients with irritable bowel syndrome.肠易激综合征患者的躯体化症状及其与压力的关联。
PLoS One. 2025 Jan 6;20(1):e0312506. doi: 10.1371/journal.pone.0312506. eCollection 2025.
3
Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome-wide association study.
肠易激综合征患者的合并症、生物标志物和病因特异性死亡率:一项表型全基因组关联研究。
United European Gastroenterol J. 2023 Jun;11(5):458-470. doi: 10.1002/ueg2.12397. Epub 2023 May 7.
4
Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome.随机临床试验:个体与团体催眠治疗肠易激综合征。
Aliment Pharmacol Ther. 2022 Jun;55(12):1501-1511. doi: 10.1111/apt.16934. Epub 2022 May 3.
5
Habitual Green Kiwifruit Consumption Is Associated with a Reduction in Upper Gastrointestinal Symptoms: A Systematic Scoping Review.习惯性食用绿奇异果与减少上消化道症状有关:系统范围审查。
Adv Nutr. 2022 Jun 1;13(3):846-856. doi: 10.1093/advances/nmac025.
6
Healthcare use by 30,000 patients with irritable bowel syndrome (IBS) in France: a 5-year retrospective and one-year prospective national observational study.法国 30000 例肠易激综合征(IBS)患者的医疗保健使用情况:一项为期 5 年的回顾性和为期 1 年的前瞻性全国观察性研究。
BMC Gastroenterol. 2019 Jun 27;19(1):111. doi: 10.1186/s12876-019-1031-z.
7
Quality of life and depression in patients with irritable bowel syndrome.肠易激综合征患者的生活质量与抑郁
Prz Gastroenterol. 2018;13(2):102-108. doi: 10.5114/pg.2018.75819. Epub 2018 May 16.
8
The mucosal immune system: master regulator of bidirectional gut-brain communications.黏膜免疫系统:双向肠脑通讯的主控调节器。
Nat Rev Gastroenterol Hepatol. 2017 Mar;14(3):143-159. doi: 10.1038/nrgastro.2016.191. Epub 2017 Jan 18.
9
Pediatric Irritable Bowel Syndrome Patient and Parental Characteristics Differ by Care Management Type.小儿肠易激综合征患者及家长的特征因护理管理类型而异。
J Pediatr Gastroenterol Nutr. 2017 Mar;64(3):391-395. doi: 10.1097/MPG.0000000000001246.
10
Cannabis Abuse Is Increasing and Associated with Increased Emergency Department Utilization in Gastroenterology Patients.大麻滥用现象日益增多,且与胃肠病患者急诊科就诊率上升有关。
Dig Dis Sci. 2016 Jul;61(7):1844-52. doi: 10.1007/s10620-016-4090-9. Epub 2016 Mar 2.